Xencor, Inc. (XNCR)
15.01
-0.16
(-1.05%)
USD |
NASDAQ |
Dec 30, 14:26
Xencor EPS Diluted (Quarterly): -0.081 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Glaukos Corp. | -0.2828 |
| Boston Scientific Corp. | 0.5048 |
| Ironwood Pharmaceuticals, Inc. | 0.2294 |
| GT Biopharma, Inc. | -0.8268 |
| Nuvalent, Inc. | -1.697 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.027M |
| Revenue (Quarterly) | 21.00M |
| Total Expenses (Quarterly) | 27.03M |
| Enterprise Value | 814.66M |
| Gross Profit Margin (Quarterly) | 87.62% |
| Profit Margin (Quarterly) | -28.70% |
| Earnings Yield | -11.83% |
| Normalized Earnings Yield | -14.64 |